Bionor Pharma ASA

Type: Company
Name: Bionor Pharma ASA
First reported 6 hours ago - Updated 6 hours ago - 1 reports

Aarhus University, Bionor Pharma Use Celgene’s Istodax To Lure HIV

By Cyndi RootResearchers from Aarhus University and Bionor Pharma presented an abstract at the Aids 2014 congress in Melbourne regarding a small study that used Celgene’s Istodax (romidepsin) to lure HIV hidden in reservoirs in the body. Driving the virus ... [Published Bioresearch Online - 6 hours ago]
First reported Jul 23 2014 - Updated Jul 24 2014 - 1 reports

Scientists Report Discovery Of Biomarker For HIV Vaccine

By Estel Grace MasangkayScientists from the University of London, St. George’s, and Bionor Pharma published the results of an exploratory analysis of a Phase II study investigating an HIV vaccine that revealed a possible biomarker for patients receiving ... [Published Bioresearch Online - Jul 23 2014]
First reported Jul 23 2014 - Updated Jul 24 2014 - 1 reports

Celgene's cancer drug promising in small HIV study

A cancer drug sold by Celgene could be used to drive HIV from hidden reservoirs within the body so the virus becomes susceptible to antiretroviral therapy, according to a new study.The results of a small study in six HIV-positive patients - reported at ... [Published PMLive - Jul 23 2014]
First reported Jul 23 2014 - Updated Jul 23 2014 - 1 reports

Celgene cancer drug reactivates latent HIV reservoirs

Bionor Pharma ASA (OSE:BIONOR) presented data at the International AIDS Society meeting that the company said show for the first time that cancer drug Istodax romidepsin can reactivate latent HIV reservoirs in HIV-infected patients. In six patients w ... [Published BioPortfolio - Jul 23 2014]
First reported Jul 22 2014 - Updated Jul 23 2014 - 2 reports

Old cancer drug smokes out HIV

In a pilot study, researchers at Aarhus University, in Denmark, gave the cancer medicine romidepsin to six HIV-infected people in an effort to provoke the virus into emerging.It worked: infusions of the drug woke the virus and caused it to start reproducing, ... [Published Times Live South Africa - Jul 22 2014]
First reported Jul 22 2014 - Updated Jul 22 2014 - 2 reports

Hope for new HIV treatment following biomarker discovery

Ratings require JavaScript to be enabled.Median HIV viral load reduction more than doubled among participants with high anti-C5/gp41732-744 antibody levels who received therapeutic HIV vaccine candidate Vacc-4x in exploratory, ad hoc, subset analysis ... [Published Medical News Today - Jul 22 2014]
First reported Jul 22 2014 - Updated Jul 22 2014 - 1 reports

New Research Finds a Way to Predict Which HIV Patients Will Respond Better to Future Therapeutic Vaccine

A new study suggests that HIV patients with a higher level of a particular biomarker may respond more favourably to an experimental  immune activating vaccineResearchers at St George’s, University of London and Norwegian vaccine company Bionor believe ... [Published Terrapinn - Jul 22 2014]
First reported Jul 18 2014 - Updated Jul 19 2014 - 4 reports

Predicting which HIV patients will respond better to future therapeutic vaccine -- ScienceDaily

A new study suggests that HIV patients with a higher level of a particular biomarker, or a measurable indicator found in the blood, may respond more favourably to an experimental immune activating vaccine.Experts at St George's, University of London, ... [Published DailyMe.Com - Jul 19 2014]
First reported Jul 18 2014 - Updated Jul 18 2014 - 1 reports

Gene That Stops Lung Cancer Spread Found

Offering hope in the fight against one of the world’s deadliest cancers, scientists have identified a gene responsible for stopping the movement of cancer from the lungs to other parts of the body.“Lung cancer, even when it is discovered early, is often ... [Published Oman Observer - Jul 18 2014]
First reported Jul 18 2014 - Updated Jul 18 2014 - 3 reports

New biomarker discovery brings HIV vaccine a step closer

By | IANS India Private Limited/Yahoo India News  –London, July 18 (IANS) The vaccine for HIV being developed by the Norwegian vaccine company Bionor Pharma could soon be a reality as researchers have found that median HIV viral load reduction more than ... [Published Yahoo! India - Jul 18 2014]
First reported Jul 10 2014 - Updated Jul 10 2014 - 1 reports

Abzena Announces Intention To Float

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE IN OR INTO THE UNITED STATES OF AMERICA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA, THE REPUBLIC OF IRELAND OR THE COMMONWEALTH OF AUSTRALIALondon, UK - Abzena Limited ("Abzena", the "Group" or the "Company"), ... [Published Noodls - Jul 10 2014]
First reported Jun 16 2014 - Updated Jun 17 2014 - 1 reports

Intention to Float - AIM

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE IN OR INTO THE UNITED STATES OF AMERICA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA, THE REPUBLIC OF IRELAND OR THE COMMONWEALTH OF AUSTRALIAABZENA ANNOUNCES INTENTION TO FLOAT16 June 2014London, UK Ken Cunningham, ... [Published MoneyAM - Jun 16 2014]

Quotes

...Steven Deeks, MD, from the University of California at San Francisco, said, "I think this is the single most important advance we've heard of at this meeting, and it's going to have a huge impact in the future."
Acknowledging the distance to go between this discovery and finding a cure for good, Dr Søgaard said: "There is still a long way to go and many obstacles to overcome before we can start talking about a cure against HIV. We have now shown that we can activate a hibernating virus with romidepsin and that the activated virus moves into the bloodstream in large amounts.”"
"It's another step towards something that might be a cure for HIV" said Ole Schmeltz, Sogaard, one of the senior researchers
"The ability to replace this daily medication with a vaccine that allows several months of being off medication, not to mention the enormous financial gains that would be delivered to health services, is a step closer with these preliminary results."

More Content

All (21) | News (20) | Reports (0) | Blogs (1) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Aarhus University, Bionor Pharma Use Celgene’s ... [Published Bioresearch Online - 6 hours ago]
Scientists Report Discovery Of Biomarker For HI... [Published Bioresearch Online - Jul 23 2014]
Celgene's cancer drug promising in small HIV study [Published PMLive - Jul 23 2014]
Celgene's cancer drug Isodax could re-activate ... [Published Pharma Letter - Jul 23 2014]
Celgene cancer drug reactivates latent HIV rese... [Published BioPortfolio - Jul 23 2014]
Old cancer drug smokes out HIV [Published Times Live South Africa - Jul 22 2014]
Hope for new HIV treatment following biomarker ... [Published Medical News Today - Jul 22 2014]
AIDS 2014: Norway's Bionor produces possible bi... [Published Fierce BioMarkers - Jul 22 2014]
Maiden AIDS vaccine could soon be a reality [Published Bio Spectrum Asia - Jul 22 2014]
New Research Finds a Way to Predict Which HIV P... [Published Terrapinn - Jul 22 2014]
Predicting which HIV patients will respond bett... [Published DailyMe.Com - Jul 19 2014]
Gene That Stops Lung Cancer Spread Found [Published Oman Observer - Jul 18 2014]
Potential biomarker may predict HIV vaccine eff... [Published Business Standard India - Jul 18 2014]
Predicting which HIV patients will respond bett... [Published Medical Xpress - Jul 18 2014]
Phase II study reveals potential biomarker for ... [Published News-Medical.Net - Jul 18 2014]
New biomarker discovery brings HIV vaccine a st... [Published Yahoo! India - Jul 18 2014]
Biomarker discovery may lead to new HIV treatment [Published Press News.org - Jul 18 2014]
Biomarker discovery may lead to new HIV treatment [Published EurekAlert! - Jul 18 2014]
Abzena Announces Intention To Float [Published Noodls - Jul 10 2014]
Intention to Float - AIM [Published MoneyAM - Jun 16 2014]
Bionor Pharma's Phase II Vacc-4x Data Published... [Published Marketwire - Breaking News Releases - Feb 11 2014]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Bionor Pharma's Phase II Vacc-4x Data Published... [Published Marketwire - Breaking News Releases - Feb 11 2014]
Therapeutic HIV Vaccine, Vacc-4x, Reduced Viral Load in HIV Patients Compared to Placebo in Largest Randomized, Placebo-Controlled Study of Its Kind in Recent History, Published in Lancet Infectious Diseases ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.